EVOLUTIONARY GENOMICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Evolutionary Genomics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2022.
  • Evolutionary Genomics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $3.19M, a 12.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $3.19M +$353K +12.4% Dec 31, 2022 10-K 2023-03-09
Q4 2021 $2.84M +$775K +37.6% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $2.06M -$312K -13.2% Dec 31, 2020 10-K 2022-03-22
Q4 2019 $2.37M +$198K +9.09% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $2.18M +$271K +14.2% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $1.9M -$279K -12.8% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $2.18M +$626K +40.2% Dec 31, 2016 10-K 2018-03-05
Q4 2015 $1.56M +$83K +5.63% Dec 31, 2015 10-K 2017-02-10
Q4 2014 $1.47M +$1.59M Dec 31, 2014 10-K 2016-02-19
Q4 2013 -$112K -$3.56K -3.28% Dec 31, 2013 10-K 2015-03-05
Q4 2012 -$109K -$3.15K -2.99% Dec 31, 2012 10-K 2014-04-16
Q4 2011 -$105K Dec 31, 2011 10-K 2013-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.